Ahmed S. Abdelsamie

Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity

Shadia A. Galal, Sarah H. M. Khairat, Fatma A.F. Ragab et al. · European Journal of Medicinal Chemistry · 2014 · 135 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives

Shadia A. Galal, Ahmed S. Abdelsamie, Harukuni Tokuda et al. · European Journal of Medicinal Chemistry · 2010 · 71 citations

Medicine, Medicinal Chemistry, Pharmacology +16

A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate <i>Pseudomonas aeruginosa</i> Biofilms

Christian Schütz, Duy‐Khiet Ho, Mostafa M. Hamed et al. · Advanced Science · 2021 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis and structure–activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor

Shadia A. Galal, Ahmed S. Abdelsamie, Salwa M. Soliman et al. · European Journal of Medicinal Chemistry · 2013 · 47 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs

Ahmed S. Abdelsamie, Samia A. Shouman, Yasmin M. Attia et al. · European Journal of Medicinal Chemistry · 2017 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14